Recurrent gene mutations in AML, such as FLT3‐internal tandem duplication (FLT3‐ITD), NPM1, and NRAS, have been reported in MS as well.23, 24, 25, 26, 27, 28, 29, 30. This evidence concerns the gene FLT3 and myeloid sarcoma.